References
- Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA. Chagas’ disease. Postgrad Med J 2006;82:788–98.
- World Health Organization. Chagas’ disease special program for research and training in tropical diseases. Geneva: WHO, 1993:67–75.
- World Health Organization. Control of Chagas’ disease. Tech Rep Ser 2002;905:1–109.
- Moncayo A. Progress towards interruption of transmission of Chagas’ disease. Mem Inst Oswaldo Cruz 1999;94:401–4.
- Urbina JA. Parasitological cure of Chagas’ disease: is it possible? Is it relevant? Mem Inst Oswaldo Cruz 1999;94:349–55.
- Rodrigues-Coura J, de Castro SL. A critical review on Chagas’ disease chemotherapy. Mem Inst Oswaldo Cruz 2002;97:3–24.
- Chena MA, Elizondo-Jimenez S, Rodríguez-Páez L, Nogueda-Torres B, Baeza-Ramírez I, Wong-Ramírez C. Trypanosoma cruzi: inhibition of α-hydroxyacid dehydrogenase isozyme II by N-allyl and N-propyl oxamates and their effects on intact epimastigotes. Mem Inst Oswaldo Cruz 2004;99:831–7.
- Elizondo S, Chena MA, Rodríguez-Páez L, Nogueda B, Baeza I, Wong C. Inhibition of Trypanosoma cruzi alpha-hydroxyacid dehydrogenase-isozyme II by N-isopropyl oxamate and its effect on intact epimastigotes. J Enzyme Inhib Med Chem 2003;18:265–71.
- Opperdoes FR. Biochemical peculiarities of trypanosomes African and South American. Br Med Bull 1985;41:130–6.
- Coronel CE, Rovai LE, Gerez de Burgos NM, Burgos C, Blanco A. Properties of α-hydroxyacid dehydrogenase isozymes from Trypanosoma cruzi. Mol Biochem Parasitol 1981;4:29–38.
- Coronel CE, Gerez de Burgos NM, Burgos C, Blanco A. Separación y propiedades catalíticas de la isoenzima de la α-hidroxiácido deshidrogenasa de Trypanosoma cruzi. Medicina (Buenos Aires) 1980;40:159–64.
- Bakker BM, Westerhoff HV, Opperdoes FR, Michels PA. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Mol Biochem Parasitol 2000;106:1–10.
- Verlinde CL, Hannaert V, Blonski C, Willson M, Périé JJ, Fothergill-Gilmore LA, et al. Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Updat 2001;4:50–65.
- Chena MA, Elizondo S, Rodríguez-Páez L, Nogueda B, Baeza I, Wong C. Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains. J Enzyme Inhib Med Chem 2005;20:189–97.
- Aguirre-Alvarado C, Zaragoza-Martínez F, Rodríguez-Páez L, Nogueda B, Baeza I, Wong C. In vitro and in vivo trypanocidal activity of the ethyl esters of N-allyl and N-propyl oxamates using different Trypanosoma cruzi strains. J Enzyme Inhib Med Chem 2007;22:227–33.
- Aldunate J, Repetto Y, Letelier ME, Morello A. The carboxyl esterases of Trypanosoma cruzi epimastigotes. Comp Biochem Physiol 1987;86:67–71.
- Repetto Y, Aldunate J, Morello A. Trypanosoma cruzi: carboxylesterase activity in intact epimastigotes. Comp Biochem Physiol B 1983;76:61–4.
- Bronfen E, Rocha FSA, Machado GBN. Isolamento de amostras do Trypanosoma cruzi por genodiagnostico e hemoculture de pacientes na fase cronica da doenca de Chagas. Mem Inst Oswaldo Cruz 1989;84:234–40.
- Chiari E, Diaz JCP, Lana M, Chiari CA. Haemocultures for the parasitological diagnosis of human chronic Chagas’ disease. Rev Soc Bras Med Trop 1989;22:19–23.
- Filardi LS, Brener Z. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Mem Inst Oswaldo Cruz 1984;79:221–5.
- Barr JC, Rose D, Jaines JM. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitaemia in mice. J Parasitol 1995;81:974–8.
- National Institutes of Health. Guide for the care and use of laboratory animals. DHEW Publication 85–123. Bethesda, MD: Office of Science and Health Reports, DRR/NIH, 1985.
- Hill KL. Biology and mechanism of trypanosome cell motility. Eukaryotic Cell 2003;2:200–8.